Reema Singh
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 22, 2023
Low fixed dose pembrolizumab with gemcitabine, vinorelbine, liposomal doxorubicin (Pembro100 -GVD) as an effective salvage regimen in relapsed refractory classical hodgkin's lymphoma and primary mediastinal B cell lymphoma.Tribikram Panda, Sujay Rainchwar, Rohan Halder
|Jul 05, 2022
Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high risk.Pallavi Mehta, Jyotsna Kapoor, Aakanksha Singh
|May 02, 2022
High Risk Acute Promyelocytic Leukemia - An Enigma for Hematologists: Optimizing Treatment with APML-4 Protocol.Jyotsna Kapoor, Sumeet Prakash Mirgh, Narendra Agrawal
|Jul 26, 2021
Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: Multicenter Retrospective Analysis.Narendra Agrawal, Reema Singh, Sanjeev Kumar Sharma
|Jul 16, 2021
Study of Three Cases of Primary Refractory T Cell ALL.Reema Singh, Narender Tejwani, Narendra Agrawal
Pageof 1
